Our Blog

Sign Up for Our Newsletter

Stay up on the latest enFuse^® technology, partnerships, events, and news by signing up to receive the once-monthly Enable Injections Newsletter direct to your inbox.

The New Patient-Centricity

The New Patient-Centricity

Enable Injections enFuse

Letter from Mike Hooven, CEO, Enable Injections

Don-Kirkpatrick-v2d

Meet Enable’s New Chief Operating Officer, New Press on enFuse®

enFuse Vial Transfer System

New Utility Patent and enFuse® Vial Transfer System Technology

Forbes-article-Enable Injections SAP

enFuse® Featured in Forbes: This Pharma Startup Could Transform How Chronic Diseases Are Treated

Enable Injections enFuse 25-mL on-body infusor

Injection Devices: Wearables, Connectivity & Patient-Centric Designs Empower Self-Administration

OnDrugDelivery article Sept 2019 - Enable Injections

Key Challenges in Successful Wearable Drug Delivery and Patient Self-Administration

The Need for Advanced Delivery Reconstitution Systems

The Need for Advanced Delivery Reconstitution Systems

Scaling for Success: Why Enable Injections Is the Earliest-Stage Adopter of SAP

Scaling for Success: Why Enable Injections Is the Earliest-Stage Adopter of SAP

Combination Products: Success Is All about the Partnerships

Combination Products: Success Is All about the Partnerships

Enable enFuse and Autonomous Manufacturing

Autonomous Manufacturing for the Innovative enFuse On-Body Infusor

drug delivery device design and human factors

The Human Element in Drug Delivery Device Design

injection science blog post - enFuse On-Body Infusor - Enable Injections

Patient Tolerability with High-Viscosity, Large-Volume Subcutaneous Infusions

Advantages of Subcutaneous Administration: FDA Approvals by Route of Administration

Advantages of Subcutaneous Drug Delivery